– Hippocrates (460-370 A.C.)
After more than 2000 years, the Scientific Community has widely recognized the central role of gut flora on people’s health. An altered microbiota can affect various organs and functions (skin, CNS, metabolism, immunity) and some probiotics can balance and modulate it.
On this basis, Cerbios-Pharma SA developed and tested some finished formulations where its own proprietary probiotic strain Enterocooccus lactis SF68® (formerly Enterococcus faecium SF68®) is mixed with other innovative functional ingredients, carefully selected by our R&D Department. Their synergic activity brings to a multilevel management of different conditions.
LACTIC ACID BACTERIA, POSTBIOTICS AND INTESTINAL MUCOSA
Postbiotics like butyrate are indicated for the dietary management of colonopathies with altered trophism of the intestinal mucosa. Alteration of gut barrier, often consequence of an unbalance of microbiota, can lead to an increase of intestinal permeability.
Product: E. lactis SF68® (lactic acid bacteria), Butyrate and L- Methylfolate.
Status: Under Development (expected by Q2-2025).
More information
If you are interested in receiving more information about our product, please click here.
